Dynamic Technology Lab Private LTD Myovant Sciences Ltd. Transaction History

Dynamic Technology Lab Private LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$11.6 - $20.44 $254,759 - $448,903	21,962 New	21,962 $394,000
Q1 2022 May 16, 2022	SELL	$11.38 - $16.4 $299,441 - $431,533	-26,313 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.31 - $23.87 $141,425 - $235,907	9,883 Added 60.15%	26,313 $410,000
Q3 2021 Nov 15, 2021	BUY	$18.94 - $26.99 $311,184 - $443,445	16,430 New	16,430 $369,000
Q2 2020 Aug 14, 2020	SELL	$7.34 - $20.84 $178,626 - $507,162	-24,336 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$6.55 - $14.76 $159,400 - $359,199	24,336 New	24,336 $184,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.